![]() |
![]() |
Cardioselective ?adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic (class II)
View more+(±)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide (±)-Atenolol (RS)-4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]BENZENEACETAMIDE (RS)-ATENOLOL 1-p-carbamoylmethylphenoxy-3-isopropylamino-2-propanol 2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide 2-(4-{2-hydroxy-3-[(1-méthyléthyl)amino]propoxy}phényl)acétamide 2-(4-{2-Hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl)acetamid 2-(4-{2-hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl)acetamide 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-acetamid 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide 2-[4-(2-Hydroxy-3-Isopropylaminopropoxy)Phenyl]Acetamide 2-[4-[2-hydroxy-3-(1-methylethylamino)propoxy]phenyl]ethanamide 2-[p-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide 2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide 4-(2-hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide Alinor Altol Ateni Atenol Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- EINECS 249-451-7 MFCD00057645 noten Seles tenlol TENORMIN Unilo uniloc Xaten
Safety Information of?Atenolol (CAS NO.29122-68-7):
Hazard Codes: Xn
Risk Statements: 22-36/37/38-20/21/22
22: Harmful if swallowed
36/37/38: Irritating to eyes, respiratory system and skin
20/21/22: Harmful by inhalation, in contact with skin and if swallowed
Safety Statements: 22-24/25-36-26
22: Do not breathe dust
24/25: Avoid contact with skin and eyes
36: Wear suitable protective clothing
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
WGK Germany: 2
RTECS: AC3600000
First Aid Measures of Atenolol (CAS NO.29122-68-7):
Ingestion:Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Inhalation:If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Skin:Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
Eyes:If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
Storage:
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 10204ug/kg (10.204mg/kg) | BEHAVIORAL: COMA CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Anesthesiology. Vol. 83, Pg. 204, 1995. |
man | TDLo | oral | 49mg/kg/30D-I (49mg/kg) | BEHAVIORAL: EXCITEMENT | Journal of Clinical Pyschopharmacology. Vol. 6, Pg. 390, 1986. |
man | TDLo | oral | 86mg/kg/60D-I (86mg/kg) | BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" | American Journal of Medicine. Vol. 85, Pg. 586, 1988. |
man | TDLo | oral | 129mg/kg/26W- (129mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: COUGH LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Annales de Medecine Interne. Vol. 148, Pg. 505, 1997. |
mouse | LD50 | intraperitoneal | 134mg/kg (134mg/kg) | ? | Toksikologicheskii Vestnik. Vol. (4), Pg. 33, 1995. |
mouse | LD50 | intravenous | 57mg/kg (57mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
mouse | LD50 | oral | 2gm/kg (2000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
mouse | LD50 | subcutaneous | > 400mg/kg (400mg/kg) | ? | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
rabbit | LD50 | intravenous | 50mg/kg (50mg/kg) | ? | Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 17, Pg. 425, 1979. |
rat | LD50 | intravenous | 77mg/kg (77mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
rat | LD50 | oral | > 2gm/kg (2000mg/kg) | ? | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
rat | LD50 | subcutaneous | > 600mg/kg (600mg/kg) | ? | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980. |
women | TDLo | oral | 16mg/kg (16mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY OBSTRUCTION | Annals of Emergency Medicine. Vol. 14, Pg. 161, 1985. |
women | TDLo | oral | 42mg/kg/3W-I (42mg/kg) | ? | British Medical Journal. Vol. 294, Pg. 1324, 1987. |
women | TDLo | oral | 1080mg/kg/78W (1080mg/kg) | BLOOD: LEUKOPENIA MUSCULOSKELETAL: OTHER CHANGES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Journal of Rheumatology. Vol. 13, Pg. 446, 1986. |
Acute toxicity - Oral, Category 4
Eye irritation, Category 2
Carcinogenicity, Category 2
Reproductive toxicity, Additional category for effects on or via lactation
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H302 Harmful if swallowed H319 Causes serious eye irritation H351 Suspected of causing cancer H362 May cause harm to breast-fed children |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P263 Avoid contact during pregnancy and while nursing. |
Response | P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/\u2026if you feel unwell. P330 Rinse mouth. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists: Get medical advice/attention. P308+P313 IF exposed or concerned: Get medical advice/ attention. |
Storage | P405 Store locked up. |
Disposal | P501 Dispose of contents/container to ... |
none
![]() |
![]() |
![]() |